Department of Cardiology, Medical University of Vienna, Vienna, Austria.
Semin Thorac Cardiovasc Surg. 2011 Autumn;23(3):203-8. doi: 10.1053/j.semtcvs.2011.09.002.
Watchful waiting is an established treatment strategy for asymptomatic patients with severe organic mitral regurgitation. It is based on indications for surgery that are based on current European Society of Cardiology and American Heart Association/American College of Cardiology guideline recommendations, which are defined by symptom onset, impairment of left ventricular function, and left ventricular enlargement. Excellent outcome is achieved when patients are periodically followed with clinical and echocardiographic examinations and when surgery is performed in expert centers. The strategy is based on the recognition of mitral regurgitation at an early symptomatic stage, avoiding a delayed referral of these patients. There is an ongoing debate about whether surgery should be performed in asymptomatic patients with preserved ventricular function. Ultimately, decision-making needs to be individualized and to take individual patient-related factors and local resources (including the natural history of the disease, the risk of surgery, and the likelihood of successful mitral valve repair) into consideration to obtain an optimal outcome with medical and surgical management.
对于无症状的严重器质性二尖瓣反流患者,密切观察等待是一种既定的治疗策略。该策略基于当前欧洲心脏病学会和美国心脏协会/美国心脏病学会指南推荐的手术指征,这些指征由症状发作、左心室功能障碍和左心室扩大定义。当患者定期接受临床和超声心动图检查,并在专家中心进行手术时,可获得良好的结果。该策略基于在早期有症状阶段识别二尖瓣反流,避免这些患者的延迟转诊。目前仍在争论是否应在无症状且心室功能正常的患者中进行手术。最终,决策需要个体化,并考虑患者相关因素和当地资源(包括疾病的自然史、手术风险和成功二尖瓣修复的可能性),以获得最佳的医疗和手术管理效果。